Evogene (EVGN) Reports Q2 Loss of $0.31/Share

Evogene (NYSE: EVGN) reported Q2 EPS of ($0.31), versus ($0.33) reported last year. Revenue for the quarter came in at $3.82 million, versus $5.36 million reported last year.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Citi raises Micron Technology price target to $1,300
• B. Riley previews Semi Cap Equipment sector ahead of Semicon West